James Bligh - CFO, Director at CDT Equity Inc.

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by James Bligh since 16 Aug 2025

Reported holdings for James Bligh in CDT Equity Inc.

Form 4 holding CFO, Director

CONDUIT PHARMACEUTICALS INC.

Security class
Stock Option (Right to Buy)
Shares / value
1,890,000
Estimated value
$173,691
Report date
18 Nov 2024
Price
$0.0919
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for James Bligh in CDT Equity Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .